1. Home
  2. KSCP vs CING Comparison

KSCP vs CING Comparison

Compare KSCP & CING Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Knightscope Inc.

KSCP

Knightscope Inc.

HOLD

Current Price

$3.66

Market Cap

42.6M

ML Signal

HOLD

CING

Cingulate Inc.

HOLD

Current Price

$5.13

Market Cap

40.5M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
KSCP
CING
Founded
2013
2012
Country
United States
United States
Employees
N/A
N/A
Industry
Telecommunications Equipment
Biotechnology: Pharmaceutical Preparations
Sector
Telecommunications
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
42.6M
40.5M
IPO Year
2022
2021

Fundamental Metrics

Financial Performance
Metric
KSCP
CING
Price
$3.66
$5.13
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
3
3
Target Price
$16.67
$31.33
AVG Volume (30 Days)
408.8K
261.4K
Earning Date
11-13-2025
11-13-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$11,610,000.00
N/A
Revenue This Year
$9.63
N/A
Revenue Next Year
$31.03
N/A
P/E Ratio
N/A
N/A
Revenue Growth
5.50
N/A
52 Week Low
$2.45
$3.20
52 Week High
$12.47
$6.74

Technical Indicators

Market Signals
Indicator
KSCP
CING
Relative Strength Index (RSI) 37.07 54.90
Support Level $4.12 $4.84
Resistance Level $4.64 $6.74
Average True Range (ATR) 0.28 0.57
MACD -0.01 -0.02
Stochastic Oscillator 1.02 27.47

Price Performance

Historical Comparison
KSCP
CING

About KSCP Knightscope Inc.

Knightscope Inc is a security technology company based in Silicon Valley. It designs, develops, manufactures, markets, and supports Autonomous Security Robots (ASRs), autonomous charging stations, the proprietary Knightscope Security Operations Center software user interface, Emergency Communication Devices platform with real-time on-site data collection and analysis and a proprietary interface for both indoor and outdoor usage. In addition, it developed and operates the Knightscope Security Operations Center (KSOC) which allows real-time data access, a service accessible to all its clients.

About CING Cingulate Inc.

Cingulate Inc is a clinical-stage biopharmaceutical company utilizing its proprietary precision timed-release drug delivery platform to build and advance a pipeline of next-generation pharmaceutical products designed to improve the lives of patients suffering from frequently diagnosed conditions characterized by burdensome daily dosing regimens and suboptimal treatment outcomes. The company focuses on the treatment of Attention Deficit/Hyperactivity Disorder (ADHD) and anxiety, and identifying and evaluating additional therapeutic area to use PTR technology to develop future product candidates.

Share on Social Networks: